# Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome

> **NCT00190866** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 210 (—)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Duloxetine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00190866
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 210 (—)
- **Last updated:** 2007-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00190866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00190866, "Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00190866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*